Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) Return on Capital Employed (2022 - 2025)

Praxis Precision Medicines has reported Return on Capital Employed over the past 4 years, most recently at 0.54% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.54% for Q4 2025, down 5.0% from a year ago — trailing twelve months through Dec 2025 was 0.54% (down 5.0% YoY), and the annual figure for FY2025 was 0.5%, up 31.0%.
  • Return on Capital Employed for Q4 2025 was 0.54% at Praxis Precision Medicines, up from 0.79% in the prior quarter.
  • Over the last five years, Return on Capital Employed for PRAX hit a ceiling of 0.41% in Q2 2024 and a floor of 2.4% in Q1 2023.
  • Median Return on Capital Employed over the past 4 years was 0.79% (2025), compared with a mean of 1.08%.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 153bps in 2024 and later crashed -37bps in 2025.
  • Praxis Precision Medicines' Return on Capital Employed stood at 2.35% in 2022, then soared by 34bps to 1.55% in 2023, then soared by 69bps to 0.49% in 2024, then decreased by -11bps to 0.54% in 2025.
  • The last three reported values for Return on Capital Employed were 0.54% (Q4 2025), 0.79% (Q3 2025), and 0.65% (Q2 2025) per Business Quant data.